Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Net Asset Value(s)
-
PCS Edventures! Announces Results for the Second Quarter of Fiscal Year 2026
-
FRO – Invitation to Q3 2025 Results Conference Call and Webcast
-
Alpha Modus Escalates AI-Retail Enforcement Campaign as New Lawsuit Advances Plan to Dominate AI-for-Retail
-
QIDI Max4: Flagship Large-Scale 3D Printer Debuts at Formnext 2025 in Germany
-
Viewbix Refines Proposed Quantum X Labs Acquisition Terms – Reduces Initial Equity to 40%
-
Enwex German Wind Futures Now Live for Trading on Abaxx Exchange
-
Legence Reports Third Quarter 2025 Financial Results
-
Erdene Files Updated Resource for the Zuun Mod Molybdenum-Copper Project
-
Emerita Intersects 9.6 Meters Grading 2.7% Copper, 1.85 g/t Gold and 6.9 Meters Grading 1.4% Copper, 1.85 g/t Gold at El Cura Deposit
-
Picard Reports Third Quarter 2025 Financial Results
-
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results
-
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
-
Atlas Energy Reports Third Quarter 2025 Financial Results
-
Guardian Capital Announces November 2025 Cash Distributions for Guardian Capital ETFs
-
Mirasol Resources Extends Closing Date of Offering
-
Victoria’s Secret & Co. Invites You to Listen to the Third Quarter 2025 Earnings Call Webcast
-
AtlasClear Holdings Reports Fiscal First Quarter 2026 Results and Provides Corporate Update Including Elimination of Prior Going Concern Uncertainty
-
AmpliTech Group, Inc. Reports Record Strong Q3 2025 Results
-
Next Hydrogen Reports Q3 2025 Financial Results
-
Beyond Meat Announces Determination of Conversion Rate for 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030
-
Legence Announces Agreement to Acquire Bowers
-
Iterum Therapeutics Reports Third Quarter 2025 Financial Results
-
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
-
Phononic Unleashes AI Data Center Performance Via Advanced Cooling With the Phononic ‘Thermal Kit’
-
Calisa Acquisition Corp Announces Separate Trading of its Ordinary Shares and Rights
-
OTC Markets Group Welcomes Frontera Energy Corporation to OTCQX
-
GlobalFoundries to Host Inaugural Business and Strategy Webinar
-
Nokia Corporation - Managers' transactions (Uitto)
-
Nokia Corporation - Managers' transactions (Sahgal)
-
Nokia Corporation - Managers' transactions (Fisk)
-
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery
-
NexLiving Communities Reports Record Q3 2025 Results and Declares Quarterly Dividend
-
AMG Announces Conversion Rate Adjustment for its 5.15% Junior Convertible Trust Preferred Securities Due 2037
-
CTO Realty Growth Provides Leasing Update at the Shops at Legacy
-
Best Instant Cash Advance Loans for Bad Credit No Credit Check, Introduced by MoneyMutual
-
Director/PDMR Shareholding
-
Bitget Wallet Expands Gas Abstraction to Morph with EIP‑7702
-
Form 8.3 - AXA INVESTMENT MANAGERS: Big Yellow Group plc
-
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day
-
Teleflex to Present at the Jefferies Global Healthcare Conference in London
-
Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes
-
CORRECTION - Vallourec – Convening of the General Meeting of Warrant Holders
-
Orion receives award for international growth from the President of the Republic of Finland
-
Form 8.5 (EPT/RI) - Team Plc
-
Form 8.5 (EPT/RI) - W.H.Ireland
-
Communiqué précisant les modalités de mise à disposition des Final Terms de l’émission de la BFCM séries 595 tranche 1
-
Costamare Bulkers Holdings Limited Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
-
New study finds half of young men at risk of problem anger
